Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 23, 2013, Pages 9523-9528

  Douaud, Gwenaëlle ^a,b   Refsum, Helga ^a,b,c   De Jager, Celeste A ^a   Jacoby, Robin ^b   Nichols, Thomas E ^a,d,e   Smith, Stephen M ^a   Smith, A David ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Causal modeling; Clinical trial; Degeneration; Hippocampus; Structural neuroimaging

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; VITAMIN B GROUP;

AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN SIZE; CEREBELLUM; DEMENTIA; ENTORHINAL CORTEX; FEMALE; FUSIFORM GYRUS; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAHIPPOCAMPAL GYRUS; PRECUNEUS; PRIORITY JOURNAL; PYRIFORM CORTEX; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WHITE MATTER;

CAUSAL MODELING; CLINICAL TRIAL; DEGENERATION; HIPPOCAMPUS; STRUCTURAL NEUROIMAGING;

ALZHEIMER DISEASE; BAYES THEOREM; ENGLAND; HIPPOCAMPUS; HOMOCYSTEINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; NERVE DEGENERATION; TEMPORAL LOBE; VITAMIN B COMPLEX;

EID: 84878719283     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1301816110     Document Type: Article

References (51)

1. Miller G (2012) Alzheimer's research. Stopping Alzheimer's before it starts. Science 337(6096):790-792.
2. Sperling RA, Jack CR, Jr., Aisen PS (2011) Testing the right target and right drug at the right stage. Sci Transl Med 3(111):111cm33.
3. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10(9):819-828.
4. Clarke R, et al. (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55(11):1449-1455.
5. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 13(4):235-239.
6. Seshadri S, et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346(7):476-483.
7. Dufouil C, Alpérovitch A, Ducros V, Tzourio C (2003) Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 53(2):214-221.
8. Smith AD (2008) The worldwide challenge of the dementias: A role for B vitamins and homocysteine? Food Nutr Bull 29(2, suppl):S143-S172.
9. Wald DS, Kasturiratne A, Simmonds M (2011) Serum homocysteine and dementia: Meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement 7(4):412-417.
10. Wald DS, Kasturiratne A, Simmonds M (2010) Effect of folic acid, with or without other B vitamins, on cognitive decline: Meta-analysis of randomized trials. Am J Med 123(6):522-527.
11. Ford AH, Almeida OP (2012) Effect of homocysteine lowering treatment on cognitive function: A systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 29(1):133-149.
12. Durga J, et al. (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial. Lancet 369(9557):208-216.
13. de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD (2012) Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial. Int J Geriatr Psychiatry 27(6):592-600.
14. Fox NC, et al. (2001) Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358(9277): 201-205.
15. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99(7):4703-4707.
16. Jack CR, Jr., et al. (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62(4):591-600.
17. Smith AD, et al. (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE 5(9):e12244.
18. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256(3):183-194.
19. Good CD, et al. (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14(1 pt 1):21-36.
20. Douaud G, et al. (2007) Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 130(pt 9):2375-2386.
21. Smith SM, et al. (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(suppl 1):S208-S219.
22. Fennema-Notestine C, et al.; Alzheimer's Disease Neuroimaging Initiative (2009) Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp 30(10):3238-3253.
23. Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV (2011) Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies. Neurobiol Aging 32(10):1733-1741.
24. Douaud G, et al. (2013) Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease. J Neurosci 33(5):2147-2155.
25. den Heijer T, et al. (2002) Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 59(5):746-748.
26. Seshadri S, et al. (2008) Association of plasma total homocysteine levels with subclinical brain injury: Cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 65(5):642-649.
27. Rajagopalan P, et al. (2011) Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport 22(8):391-395.
28. Kravitz DJ, Saleem KS, Baker CI, Mishkin M (2011) A new neural framework for visuospatial processing. Nat Rev Neurosci 12(4):217-230.
29. Desikan RS, et al. (2009) Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 132(pt 8):2048-2057.
30. Desikan RS, et al. (2008) MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology 71(11):819-825.
31. Schmahmann JD (2010) The role of the cerebellum in cognition and emotion: Personal reflections since 1982 on the dysmetria of thought hypothesis, and its historical evolution from theory to therapy. Neuropsychol Rev 20(3):236-260.
32. Svoboda E, McKinnon MC, Levine B (2006) The functional neuroanatomy of autobiographical memory: A meta-analysis. Neuropsychologia 44(12):2189-2208.
33. Habas C, et al. (2009) Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci 29(26):8586-8594.
34. Filippini N, et al. (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA 106(17):7209-7214.
35. Green R, Miller JW (2005) Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med 43(10): 1048-1051.
36. Whitwell JL, et al. (2008) MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study. Neurology 71(10):743-749.
37. Popp J, et al. (2009) Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. Journal of Alzheimer's disease: JAD 18:819-828.
38. Zhang CE, et al. (2008) Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol Aging 29(11):1654-1665.
39. Zhao C, Deng W, Gage FH (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132(4):645-660.
40. Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer's disease. Molecular neurodegeneration 6:85.
41. Gould E (2007) How widespread is adult neurogenesis in mammals? Nat Rev Neurosci 8(6):481-488.
42. Ma DK, et al. (2010) Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat Neurosci 13(11):1338-1344.
43. Weir DG, Scott JM (1999) Brain function in the elderly: Role of vitamin B12 and folate. Br Med Bull 55(3):669-682.
44. Rabaneda LG, et al. (2008) Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression. FASEB J 22(11):3823-3835.
45. Battaglia-Hsu SF, et al. (2009) Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE. Proc Natl Acad Sci USA 106(51):21930-21935.
46. Carter CS, Heckers S, Nichols T, Pine DS, Strother S (2008) Optimizing the design and analysis of clinical functional magnetic resonance imaging research studies. Biol Psychiatry 64(10):842-849.
47. Petersen RC, et al. (2009) Mild cognitive impairment: Ten years later. Arch Neurol 66(12):1447-1455.
48. Pfeiffer CM, et al. (2008) Trends in circulating concentrations of total homocysteine among US adolescents and adults: Findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys. Clin Chem 54(5):801-813.
49. Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum Brain Mapp 15(1):1-25.
50. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44(1):83-98.
51. Ramsey J, Zhang J, Spirtes P (2006) Adjacency-faithfulness and conservative causal inference. Proceedings of the 22nd Annual Conference on Uncertainty in Artificial Intelligence (UAI-2006) (Association for Uncertainty in Artificial Intelligence, Arlington, VA), pp 401-408.